The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
BioMarin Pharmaceutical Australia Pty Ltd
Regulatory activities for this sponsor.
Loading...
Sponsor content
5 result(s) found, displaying 1 to 5
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for VOXZOGO vosoritide 0.4 mg powder for injection vial and diluent pre-filled syringe.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for VOXZOGO vosoritide 0.56 mg powder for injection vial and diluent pre-filled syringe.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for VOXZOGO vosoritide 1.2 mg powder for injection vial and diluent pre-filled syringe.
-
Prescription medicine decision summaryTGA decision: VOXZOGO (vosoritide) is approved to treat achondroplasia in patients 2 years of age and older whose epiphyses are not closed.
-
Prescription medicine registrationActive ingredients: vosoritide.